
    
      This protocol is to collect blood and HSPC specimens from individuals with Pompe Disease. The
      first blood draw will be done at the first study visit and if eligible, the second collection
      will be done via mobilized leukapheresis at the second visit. The mobilized leukapheresis
      procedures will follow the facility's standard operating procedures and protocol requirements
      for mobilized leukapheresis.

      Donors will be males or females between and including the ages of 3 years and 30 years.
      Volunteers will provide written informed consent and meet all inclusion and exclusion
      criteria. Each participant can be in the study for up to 120 days (3 months).

      The study will be conducted in accordance with human research for the purposes of obtaining
      clinical specimens for research. There is no endpoint for this study, however, data collected
      from this study will include, but not be limited to, gender, demographics, medical history,
      clinical laboratory values, and volume of the blood collected. The data will be summarized in
      future studies reporting results from a future clinical trial under FDA IND.
    
  